This document provides an overview about what we have done and can do in area of strategy consulting for healthcare industry.

1. © Profound Healthcare Services, 2014
This document is solely for the use of client personnel only. No part of it may be circulated, quoted or reproduced for distribution outside of client’s
organization without prior written approval of Profound Healthcare Services
Strategy Consulting
MARKET INTELLIGENCE. PROCESS SUPPORT.

2. 2 Profound Healthcare Services - Credentials
Contents
•Introduction
•Offerings and projects done
− Strategy Consulting
− Market Intelligence
− Process Management
− Pharma Chronicle
•Team

3. 3 Profound Healthcare Services - Credentials
Contents
•Introduction
•Offerings and projects done
− Strategy Consulting
− Market Intelligence
− Process Management
− Pharma Chronicle
•Team

4. 4 Profound Healthcare Services - Credentials
Profound Healthcare Services assists pharma companies in taking
informed decisions through a basket of services
About us
− Profound Healthcare Services was started in June 2012, by ex-IMS consultants, with an objective of providing spread
of services to pharma industry
− We cater to various types of clients in the healthcare segment – i.e. Pharma, Med Tech, Healthcare consulting &
investors, Specialty chains / clinics
Service segments

5. 5 Profound Healthcare Services - Credentials
Clients
In a short span of two years, we had the opportunity to serve
some of the leaders from various segments of Pharma market
Partner Point
SHARDA CHEM
INTERNATIONAL

6. 6 Profound Healthcare Services - Credentials
Our four offering segments are targeted at assisting you in
strategic and tactical measures in complex business environment
Contemporary business environment
External Business Environment - Macro
Political
Economic
Social
Technology
Legal
External Business Environment
- Micro
Competition
Value chain
Consumers
New launches
Regulations
Internal Business
Environment
Business
processes
Employees
Process Management
Market Intelligence
Pharma Chronicle
StrategyConsulting

7. 7 Profound Healthcare Services - Credentials
Our strategy consulting and market intelligence offerings assist
clients in growth in different ways
Our services mapped on the Ansoff’s growth matrix
Market IntelligenceStrategy Consulting
Market development Diversification
Market Penetration
Product Launches
Growth
Market
ProductExisting New
Existing
New
Market entry strategy
Growth strategy & CI
Portfolio optimization
Portfolio design
Portfolio design
Market assessment
Market sizing
Brand growth
driver
assessment
Market assessment
Benchmarking1
NOTE: 1) Benchmarking for field force, brands and company level strategies

8. 8 Profound Healthcare Services - Credentials
Our team profile, robust methodologies / models and industry
network help us deliver high quality outputs
Why us?
Exclusive Healthcare
focus and experience
• We focus exclusively on the healthcare sector
• Experienced in multiple therapy area assessment across acute / chronic segments
Strong Industry Network
• Strong network of highly experienced professionals from Indian pharma industry
• Established access to KOLs across major therapy areas
High quality insights
• We take a solution oriented approach to go beyond pure data generation
• Provide high quality insights and implementable recommendations
• Personal involvement in insight generation leads to highest quality of market
intelligence
• Blend of market research and consulting experience
• Total experience of 7+ years in Healthcare Consulting, including 5 years in IMS
Consulting
Strong Team Background
Robust methodologies
and frameworks
• Robust analysis based upon internally developed analytic models
• Scientific methodology customized as per project need
• Specific models (e.g. forecasting model) are shared with client as a deliverable

9. 9 Profound Healthcare Services - Credentials
Our earlier experience in healthcare consulting also spans across
a very broad spectrum of delivery areas
We have been a part of multiple consulting engagements in each
of the following areas
• India entry strategy for new MNCs entering Indian market
• Growth strategy for large Indian companies
• New therapeutic area entry strategy for existing players
• Portfolio optimization for existing players
• Portfolio selection for new entrants and forecasting with
P&L
• Qualitative primary market research for market size
estimation MNCs
• Brand awareness primary market research for international
brands
• Pricing and market access studies
Overall Experience
• Super-specialty –
Neurology, Oncology,
Diabetology, CVS,
Rheumatology,
Gastroenterology,
Nephrology, Infertility, etc.
• Specialty – Internal
Medicine (CP),
Gynaecology, Paediatrics,
Surgery, Orthopaedics,
Ophthalmology, GP, etc.
Therapy areas experienceDelivery areas experience

10. 10 Profound Healthcare Services - Credentials
Contents
•Introduction
•Offerings and projects done
− Strategy Consulting
− Market Intelligence
− Process Management
− Pharma Chronicle
•Team

11. 11 Profound Healthcare Services - Credentials
Strategy consulting usually involves a scientific approach
leading to strategy recommendation supported by financials
Strategy Consulting – typical approach
• Typically 12-16 weeks duration1
• High involvement of client essential at each stage
NOTE: 1) Timelines are rough estimates, actual timeline would be defined based upon the scope of each engagement and would differ for each
engagement
Illustrative
Recommendation
with financial
analysis
• Financial analysis
• Client meetings
• Final recommendation
Detailed market
assessment
• Ongoing desk research
• Building DGs
• Pilot research
• Primary market research
• Validation & bridging
gaps from experts
Validate internal
aspirations
• Internal meetings
• Basic desk research
as needed
Analysis and
strategy framework
• Data collation
• Analysis through existing
/ customized tools
• Developing strategy
framework
• Identification of strategic
options
Identify issues
• Analysis of findings
from internal meetings

12. 12 Profound Healthcare Services - Credentials
Case studies
Nature of Engagement Client What we did? Benefit to client
Market entry strategy
for own marketing of
Gynec manufacturer in
India
A leading
Indian
manufacturer
of hormones
and
contraceptives
• Provided detailed understanding of
market dynamics through desk research
and data analysis
• Recommended product portfolio based on
a detailed market research & internal tools
• Forecast for the products under
consideration based upon doctor
feedback
• End to end entry strategy with
implementation plan, field force
requirements, organization structure and
P&L
• Identification of operating segments
• Dynamics of a completely new
market
• Implementable recommendations for
market entry
• Detailed financial analysis with P&L
• “Go-no go” recommendation
Optimize the women’s
health portfolio for a
additional division
A Global
leader in
Gynecology
• We did secondary research, discussions
with KOLs, looked at new launches,
pipeline, clinical trail data, molecules
available in international markets
• Identified new opportunities for portfolio
for immediate launch
• Identified futuristic opportunities, with
qualitative feedback from KOLs
• Detailed KOL feedback on 65
products
• Dynamic forecast model for the same
• A differentiated & customized
portfolio of 50 molecules
• Directional inputs for BD and R&D
teams through 17 prioritized, futuristic
products focusing beyond 3 years
We have delivered one entry strategy and one portfolio strategy
engagement

13. 13 Profound Healthcare Services - Credentials
Case study slides

14. 14 Profound Healthcare Services - Credentials
Case study: India entry and go to market strategy for a new
player entering the Gynec market in India
• Understand the growth plans
• Understand key expectations
• Market Assessment – through
initial desk research / industry
expert feedback
• Develop consensus on next
steps and project milestones
• Ratify key portfolio
opportunities in line with
consensus – through
external datasets, KOL /
expert feedback
• Evaluate and finalize
portfolio – with 3 yr top-line
forecasts
• Forecasting for Gynaec BU
– overall 3 yr forecast for the
Gynaec BU
• Assess other go to market
options – S&T strategy, SF
structure & FF sizing
• Evaluate findings and
recommend entry strategy
– Define divisional structure,
cost & profitability of that
structure. Compare options,
prioritize and recommend
operating model
• Develop overall
implementation plan –
across functions with clear
responsibilities, timelines &
key milestones
• Convert implementation
plan into financials, as
necessary. Develop
consensus
Review growth plans and
vision
Assess and Evaluate
Portfolio
Opportunities
Align field force and
recommend entry
strategy
Develop Implementation
Agenda
Benefits for client: Client was able to arrive at a final “go / no-go” decision based upon in-depth financial
analysis and subsequent recommendations
Strategy Consulting
Back

15. 15 Profound Healthcare Services - Credentials
Case study: Optimization of women’s health portfolio focusing
on KOLs with infertility & pregnancy maintenance practice (1/2)
Strategy Consulting
Benefits for client:
Client was able to get
a differentiated portfoli
o that was tailor made
for that division.
Portfolio
included prioritized 17
molecules that could
form a futuristic
portfolio beyond 3
years of
division launch
Stage I:
Studying target
market
• Understand internal
aspirations
• Study external business
environment
• Define the target market
Stage II:
Developing long list
of products
• Analyse existing portfolio
• Assess the initial list
• Arrive at long list of
potential molecules
Stage III:
Forecasting & final
portfolio
• Generate doctor feedback
• Build product level
forecast
• Recommend final portfolio
NOTE: Stages II & III are depicted in detail on the following slide
Back

16. 16 Profound Healthcare Services - Credentials
Immediate Portfolio (Phase I) Process
All
molecules
identified in
landscaping
Initial
screening
for obvious
exclusions
and
identifying
gaps
Opportunity
vs.
operating
barriers
analysis
Long list of
molecules
for final
ratification
Doctor
feedback
and internal
data
analysis
Forecasting
Final short-
listed
portfolio
Stage IIStage I Stage III
841
65
126
Depth discussions
with 44 Gynecs
58
1. New molecules in IPM
2. Novel products identified in stage I&II
3. New products of specific identified
companies
4. Client pipeline
17
44
21
Legend:
SOURCES
• Gynecologist KOLs
• Industry Experts
• International Markets
• Secondary sources
Identified products
suitable for various
areas
Shortlisted
products for further
study
Additional list of
products
36
18 24
Futuristic Portfolio (Phase II) Process
Qualitative
feedback from
KOLs
Case study: Optimization of women’s health portfolio focusing
on KOLs with infertility & pregnancy maintenance practice (2/2)
Back
Strategy Consulting

17. Girish Korde
+91 98197 21479
gkorde@profoundhs.in
Thank You!